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Treatment with a DNA methyltransferase 
inhibitor feminizes zebrafish and induces 
long-term expression changes in the gonads
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Abstract 
Background: The role of epigenetic modifications such as DNA methylation during vertebrate sexual development 
is far from being clear. Using the zebrafish model, we tested the effects of one of the most common DNA methyl-
transferase (dnmt) inhibitor, 5-aza-2′-deoxycytidine (5-aza-dC), which is approved for the treatment of acute myeloid 
leukaemia and is under active investigation for the treatment of solid tumours. Several dose–response experiments 
were carried out during two periods, including not only the very first days of development (0–6 days post-fertilization, 
dpf ), as done in previous studies, but also, and as a novelty, the period of gonadal development (10–30 dpf ).
Results: Early treatment with 5-aza-dC altered embryonic development, delayed hatching and increased teratology 
and mortality, as expected. The most striking result, however, was an increase in the number of females, suggesting 
that alterations induced by 5-aza-dC treatment can affect sexual development as well. Results were confirmed when 
treatment coincided with gonadal development. In addition, we also found that the adult gonadal transcriptome 
of 5-aza-dC-exposed females included significant changes in the expression of key reproduction-related genes (e.g. 
cyp11a1, esr2b and figla), and that several pro-female-related pathways such as the Fanconi anaemia or the Wnt sig-
nalling pathways were downregulated. Furthermore, an overall inhibition of genes implicated in epigenetic regulatory 
mechanisms (e.g. dnmt1, dicer, cbx4) was also observed.
Conclusions: Taken together, our results indicate that treatment with a DNA methylation inhibitor can also alter the 
sexual development in zebrafish, with permanent alterations of the adult gonadal transcriptome, at least in females. 
Our results show the importance of DNA methylation for proper control of sexual development, open new avenues 
for the potential control of sex ratios in fish (aquaculture, population control) and call attention to possibly hidden 
long-term effects of dnmt therapy when used, for example, in the treatment of prepuberal children affected by some 
types of cancer.
Keywords: 5-Aza-dC, Methylation, dnmt, Sex ratio, Epigenetic, Reproduction, Zebrafish
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
DNA methylation is one of the main epigenetic modifi-
cations involved in gene expression regulation. In verte-
brates, it consists in the addition of a methyl group to 
the 5′ position of cytosine followed by a guanine (CpG) 
[1, 2]. Proper control of DNA methylation is essential 
for many phenomena, including X-chromosome inac-
tivation [3], genomic imprinting [4] or ageing [5]. DNA 
methylation is carried out by enzymes named DNA 
methyltransferases (dnmts) [6]. In mammals, the main 
dnmts include one responsible for DNA methylation 
maintenance (dnmt1) and another two for de novo 
DNA methylation (dnmt3a/b) [7, 8]. Addition of methyl 
groups to CpGs by dnmts can prevent transcription 
factor binding and hence gene expression [6, 9]. Many 
studies have focused on the consequences of DNA 
methylation alterations by using dnmt inhibitor agents 
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to control the expression of genes involved in the onset 
of cancer [10]. Furthermore, many tumour cells have 
hypermethylation in the promoters of tumour suppres-
sor genes [11, 12] and thus research has also contem-
plated the effects of demethylating agents to regain the 
expression of these silenced genes [13, 14].
The most popular demethylation agents are 5-azacytidine 
(5-aza-CR), 5-aza-2′-deoxycytidine (5-aza-dC), commonly 
named as decitabine, and zebularine. 5-Aza-dC is more 
potent than 5-aza-CR, but both are more toxic and unstable 
than zebularine [14, 15]. These agents block DNA methyla-
tion when incorporated in the DNA as cytidine nucleoside 
analogues [16], forming a covalent bond in which dnmts 
become removed from the active nuclear pool and the 
genome results hypomethylated [17, 18]. However, despite 
many studies on the underlying biochemical reactions tak-
ing place in cells exposed to these agents, their exact in vivo 
mechanism still remains unclear [18, 19].
In recent years, zebrafish (Danio rerio)  has become 
widely accepted as a model for the study of epige-
netic regulatory mechanisms, which are generally con-
served with respect to those of mammals [20, 21]. Thus, 
for example, epigenetic alterations that occur dur-
ing germ cell development are common between mice 
and zebrafish [22, 23]. The paternal zebrafish methyl-
ome is inherited through the sperm. After fertilization, 
the maternal zebrafish methylome is reprogrammed to 
match the paternal methylome [22, 24]. Subsequently, 
during earlier development stages, about 80% of the 
CpGs in the zebrafish genome are methylated with some 
fluctuations along development, i.e. blastula and gastrula 
stages [25, 26].
Few studies have investigated the effects of dnmt 
inhibitors in fish models. In zebrafish, demethylation 
agents have been used to better understand the role 
of DNA methylation during early development, where 
lack of proper DNA methylation resulted in different 
types of malformations [27]. Cranial deformities were 
also observed in another fish model, the Japanese rice 
fish (Oryzias latipes), after early exposure to 5-aza-CR 
[28]. As it occurs in mammalian cells [17, 29], treat-
ment of zebrafish with 5-aza-CR results in global hypo-
methylation in embryonic cells [30] as well as in adult 
hepatocytes [31]. In female zebrafish fed by 5-aza-dC 
during 32  days a decrease in global DNA methylation 
was observed [32], likewise, in larvae treated with 10 or 
25  µM during 0–6  dpf [33]. However, transgenerational 
effects up to the F2 generation were only observed in the 
latter study [33]. Few data are found in parental imprint-
ing in fish gametes (reviewed in [34]), a process responsi-
ble for the heritance of the DNA methylome. In zebrafish, 
it has been documented that dynamic changes in DNA 
methylation occur during imprinting [25] and that the 
DNA methylome is inherited through the sperm, but no 
through the oocyte [22].
During the last few years, the importance of epigenetic 
regulatory mechanisms for sexual development has been 
realized, particularly in organisms where sex is the result of 
the interplay between genetic and environment (reviewed 
in [35]). Thus, in fish the methylation levels of the pro-
moter of gonadal aromatase (cyp19a1a)—the enzyme that 
converts androgens to oestrogens—in the European sea 
bass, Dicentrarchus labrax, were positively correlated with 
temperature during early development [36]. In the olive 
flounder, Paralichthys olivaceus [37] and in zebrafish [38] 
cyp19a1a methylation levels during ovarian development 
have been studied, showing different methylation pat-
terns during folliculogenesis. Whole-genome approaches 
have revealed global hypermethylation in various chro-
mosomes in the gonads of Nile tilapia, Oreochromis niloti-
cus, exposed to elevated temperatures when compared 
to control fish [39]. Also, in the half-smooth tongue sole, 
Cynoglossus semilaevis, genome-wide DNA methylation 
analysis revealed the existence of an epigenetic regula-
tory mechanism on the suppression of the female-specific 
W chromosomal genes in high-temperature masculinized 
fish [40]. However, the role of DNA methylation during 
gonadal development is far from being clear.
The zebrafish is also increasingly becoming a useful 
model for aquaculture-related research, where, for exam-
ple, the control of sex ratios is pursued due to the fre-
quent sexual dimorphism in growth [41]. Domesticated 
zebrafish have a polygenetic sex-determining system in 
which genetic factors in combination with environmen-
tal factors determine the sexual phenotype [42, 43]. In 
contrast, wild zebrafish has a chromosomal (WZ/ZZ) sex 
determination system [44]. Thus, domesticated zebrafish 
is a well-suited model for studying the effects of environ-
mental perturbations on its development, particularly 
sexual development. After preliminary trials, in this study 
we report the establishment of the appropriate condi-
tions for treatment of zebrafish with the most common 
dnmt inhibitor, 5-aza-dC. Importantly, treatments were 
not limited to embryonic development, as done earlier, 
but included treatments covering the period of gonadal 
development. We report the effects of dose, timing and 
duration of treatment with 5-aza-dC in terms of result-
ing survival, deformities and growth. Interestingly, we 
show that treatment with 5-aza-dC consistently results 
in an increase in the number of females after different 
treatments, opening the possibility for a new approach 
to study the epigenetic regulation of sex and its control, 
and provide a detailed description of the effects on the 
gonadal transcriptome as a result of 5-aza-dC treatment. 
We also raise the possibility that some of the novel effects 
found in zebrafish ovaries could also be happening in 
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other vertebrates, including humans, particularly prepu-
beral children affected by some types of cancer, where 
treatment with DNA-demethylating agents is clinically 
used.
Results
5‑Aza‑dC decreases survival and induces teratologies 
when administered during zebrafish early development
Early development experiments
Treatment of zebrafish eggs with 5-aza-dC at 0, 5, 15 or 
25  µM added to the embryo medium from 0 to 6  days 
post-fertilization (dpf) resulted in a progressive decrease 
in survival at the end of the treatment: 75.3, 62, 66 and 
44%, respectively. At 30  dpf, these survival values had 
further dropped to 34, 42, 44 and 26%, respectively.
Treatment of eggs with 5-aza-dC at 75  µM from 0 to 
2  dpf resulted in significantly (P  <  0.05) lower survival 
at 8  dpf but not before (Fig.  1a). A non-significant delay 
on development, as assessed by hatching rate, was also 
observed (Fig.  1b). Teratologies were already observed at 
2 dpf in two out of seven tested families, but in all of them 
teratology was observed between 3 and 4  dpf onwards 
(Fig. 2); however, significant differences (P < 0.05) were not 
found until 4 days and onwards, with ~ 75% of the surviving 
treated fish affected at 8 dpf (P < 0.05; Fig. 1c). Teratologies 
included three major types: body curvature, reduced yolk-
sac reabsorption and overall body deformation (Fig. 2).
Gonadal development experiments
Treatment of larvae with 5-aza-dC at 25 µM at different 
periods during gonadal development resulted in signifi-
cantly (P  <  0.05) lower survival, particularly if the treat-
ment started at 10  dpf and lasted until 30  dpf (Fig.  1d). 
Differences in survival persisted until the end of the 
experiment at 90 dpf only in the fish treated from 10 to 
30 dpf. Survival of fish treated only between 10 and 20 dpf 
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Fig. 1 Zebrafish treated with 5-aza-dC. a Survival, b hatching rate and c teratology of zebrafish embryos treated with 5-aza-dC at 75 µM from 0 
to 2 dpf. Each shown datapoint is the mean ± s.e.m. of seven independent experiments. Within each experiment, each datapoint is the mean of 
three technical replicates. Significant differences P < 0.05 (in a) or P < 0.01 (in c) among groups at a given age are indicated by different letters 
and were examined by Student’s t test. d Survival of treated zebrafish with 25 µM of 5-aza-dC during gonadal development. Each datapoint is the 
mean ± s.e.m. of two independent experiments. Within each experiment, each datapoint is the mean of 2–4 technical replicates, originated from 
five breeding pairs. Significant differences (P < 0.05) among groups at a given sampling age were tested by one-way ANOVA and are indicated by 
different letters
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was also significantly (P < 0.05) reduced from 15 to 30 dpf 
but stabilized at 40 dpf, without differences with the con-
trols. No differences in fish survival were found in the 
20–30-dpf period when compared to controls (Fig. 1d).
The survival of fish treated with 5-aza-dC at the highest 
concentration (75 µM) from 10 to 30 dpf was reduced to 
56% one week after starting the treatment (17 dpf) and to 
42.6% at the end of the treatment (30 dpf). At 90 dpf, sur-
vival of treated fish was only 13.3%. Furthermore, surviv-
ing fish were smaller than the controls (Additional file 1: 
Fig. S1A) both in standard length (SL) in males (P < 0.05) 
and in females (P  <  0.01) and in body weight (BW) in 
males (P < 0.05) and females (P = 0.08) (Additional file 1: 
Fig. S1 B, C).
5‑Aza‑dC treatment consistently alters the sex ratio
In this study, the number of males in the control groups 
of the different experiments was in the range of 60–75%, 
a typical value for domestic zebrafish (AB strain). Treat-
ment with 5-aza-dC at 75  µM from 0 to 2  dpf signifi-
cantly (P < 0.05) reduced the number of males at 90 dpf 
(Fig.  3a). Furthermore, a clear dose–response effect 
was elicited when treatment was carried out from 0 to 
6  dpf (Fig.  3b), with significant differences (P  <  0.05) in 
the number of males with respect to the untreated con-
trols observed with the 15- and 25-µM doses. Consistent 
with these results, the number of males also decreased in 
fish treated with 5-aza-dC at 25 µM when the treatment 
included the 20–30- or 10–30-dpf periods; however, sig-
nificant differences (P  <  0.05) could be recorded only in 
the 20–30 dpf due to the lack of replication in the 10–30-
dpf period. In contrast, no significant differences in sex 
ratio were observed when treatment took place during the 
10–20-dpf period. As stated in the previous section, lar-
vae treated with 5-aza-dC fish at 75 µM from 10 to 30 dpf 
had very low survival. Therefore, in this group sex ratios 
could not be assessed accurately due to the low number of 
fish available for statistics. Taken together, the data shown 
above indicate that treatment with 5-aza-dC is able to 
alter sexual development in zebrafish.
Long‑term effects of 5‑aza‑dC treatment on the expression 
of dnmt1 and dnmt3b
Treatment at 75  µM from 0 to 2  dpf did not affect the 
expression of the dnmt1 (Fig. 4a) and dnmt3 (specifically, 
dnmt3bb.2, which will be referred to as dnmt3b in the rest 
of the paper for simplicity) (Fig. 4b) in 4-dpf larvae. In addi-
tion, 5-aza-dC did not alter the expression of dnmt1 in the 
gonads of 90-dpf adults (Fig. 4c), but significantly (P < 0.05) 
decreased the expression of dnmt3b in testes (Fig. 4d). No 
effects were observed in 30-dpf juveniles after treatment 
at 25 µM from 0 to 6 dpf (Fig. 4e, f ). However, the same 
dose administered between 20 and 30  dpf significantly 
(P < 0.05) increased dnmt1 expression at 30 dpf (Fig. 4g), 
while dnmt3b expression was not affected (Fig. 4h).
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Fig. 2 Representative teratology observed from zebrafish embryos 
treated with 5-aza-dC at 75 µM from 0 to 2 dpf. Teratology was 
observed from 2 dpf in two out of seven families, and between 3 
and 4 dpf, it was observed in all tested families. Different types of 
teratologies were observed; body curvature, problems with yolk-sac 
reabsorption and body deformation
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Effects of 5‑aza‑dC on the ovarian transcriptome of treated 
females include downregulation of reproduction‑related 
signalling pathways and a repression of genes related 
to epigenetic regulatory mechanisms
Since treatment with 5-aza-dC affected sex ratios by 
increasing the number of females, we wanted to exam-
ine the ovarian transcriptome of females resulting from 
exposure to 5-aza-dC. To do this, we compared females 
treated with 5-aza-dC at 75 µM from 10 to 30 dpf during 
the gonadal development period (Fig. 3c) with untreated 
females from the control group (n = 4 fish per group) as 
that was the group that showed the highest differences 
in growth in comparison with the lowest concentration 
(25  µm), suggestive of clear treatment effects. Expres-
sion profiles using a zebrafish homologous microarray 
(see materials and methods) were subjected to principal 
component analysis (PCA), which classified the samples 
into two clusters corresponding to control and treated 
fish. The PCA component 1 alone explained 64.0% of 
the variance, while component 2 explained an additional 
10.6% (Fig.  5a). Between the two groups, there were a 
total of 998 differentially expressed genes (DEG), with 
298 up- and 700 downregulated genes with a fold change 
(FC) ≥ 1.2 including both upregulation and downregula-
tion and a P value < 0.01 (Fig. 5b). Likewise, the number 
of up- and downregulated DEG with a FC ≥ 2 was 74 and 
30, respectively (Fig.  5b). Validation by quantitative (q) 
PCR using DEG between the two groups, and primarily 
related to reproduction, showed that the results obtained 
matched those obtained with the microarray (R2 = 0.963, 
P  <  0.0001), thus validating the microarray data (Addi-
tional file 2: Fig. S2).
In all gene ontology (GO) terms identified by analysing 
level 3, a larger number of downregulated GO terms were 
found (76) in comparison with the upregulated terms 
(43) (Additional file  3: Table S1, Additional file  4: Fig. 
S3). In the upregulated terms in the Biological process 
category (Additional file 4: Fig. S3A), the most enriched 
subcategories were: multicellular organism develop-
ment (GO:0007275), system development (GO:0048731) 
and animal organ development (GO:0048513). The 
most downregulated subcategories (Additional file  4: 
Fig. S3D) were: cellular nitrogen compound metabolic 
process (GO:0034641), cellular macromolecule meta-
bolic process (GO:0044260) and nucleobase-contain-
ing compound metabolic process (GO:0006139). We 
also found a downregulation of a GO term directly 
related to methylation: methylation-dependent chro-
matin silencing (GO:0006346) (Additional file  4: Fig. 
S3D). In the Cellular component category (Additional 
file 4: Fig. S3B, E) only seven GO terms were character-
ized in the upregulated subcategory. Likewise, we iden-
tified 20 downregulated subcategories, most of them 
with a high significant enriched p value (p = 1E−23–E−4), 
Fig. 3 Effects of treatment with 5-aza-dC on the resulting sex ratio 
at 90 dpf. a Sex ratio of fish treated with 5-aza-dC at 75 µM from 
0 to 2 dpf. Each datapoint is the mean ± s.e.m., corresponding to 
five independent experiments using five different breeding pairs. 
Numbers of fish are 162 and 81 in control and 5-aza-dC, respectively. 
Significant differences among groups (P < 0.05) were analysed by 
the Chi-squared test with Yate’s correction. b Sex ratio of zebrafish 
larvae (0–6 dpf ) treated with different 5-aza-dC doses (0, 5, 15, 25 µM 
n = 13, 27, 31, 19, respectively). Each datapoint is the mean ± s.e.m. 
of two independent experiments with two technical replicates 
each. c Sex ratio of zebrafish treated with 25 µM of 5-aza-dC during 
different periods during gonadal development. Data shown as 
mean ± s.e.m. of three independent experiments with 1–3 biological 
replicates (n = 133, 59, 72 and 11 in control, 10–20 dpf, 20–30 dpf 
and 10–30 dpf groups, respectively). Significant differences among 
groups were analysed by the Chi-squared test with Yate’s correction. 
Significant differences (P < 0.05) are indicated by different letters. N/A, 
variation not assessed because there was only one experiment one 
technical replicate
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Fig. 4 Gene expression profiles of DNA methyltransferases 1 and 3 (dnmt1 and dnmt3b) in zebrafish treated with 5-aza-dC. a, b 0–2-dpf treatment, 
short-term effects. Gene expression of dnmt1 (a) and dnmt3b (b) in larvae at 4 dpf previously treated with 5-aza-dC at 75 µM from 0 to 2 dpf. Each 
datapoint is the mean ± s.e.m., corresponding to 5 pools of larvae each, in turn, made of a pool of ~ 20 larvae from two independent experiments. 
b, c 0–2-dpf treatment, long-term effects. Gene expression of dnmt1 (c) and dnmt3b (d) in zebrafish gonads at 90 dpf after treatment with 5-aza-dC 
at 75 µM from 0 to 2 dpf. Data shown as mean ± s.e.m. of fold change using control values set at 1. Sample size n = 7–9 gonads per sex and treat-
ment. Within the same sex, different letters indicate significant differences (P < 0.01) between treated and control fish analysed by Student’s t test. e, 
f 0–6-dpf treatment, mid-term effects. Gene expression of dnmt1 (e) and dnmt3b (f) in juvenile fish at 30 dpf treated with 5-aza-dC at 25 µM in the 
period 0–6 dpf. Each datapoint is the mean ± s.e.m. with n = 7 individual larvae corresponding to 3 technical replicates. The same letter between 
groups indicates no significant differences (P > 0.05) among groups were tested by Student’s t test. g, h 20–30-dpf treatment, short-term effect. 
Gene expression of dnmt1 g and dnmt3b h in body trunks of juvenile zebrafish at 30 dpf after treatment from 20 to 30 dpf with 25 µM 5-aza-dC. 
Data shown as mean ± s.e.m. fold change of n = 12 samples per group using control values set at 1. Significant differences (P < 0.05) are indicated 
by different letters
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i.e. intracellular (GO:0005622) and intracellular part 
(GO:0044424). For the Molecular process (MP) cat-
egory (Additional file  4: Fig S3 C, F) the most enriched 
downregulated GO term was related to epigenetics: chro-
matin binding (GO:0003682).
We identified a total of 24 DEG involved in reproduc-
tion-related functions [43, 45–47] (Additional file  5: 
Table S2) of which 17 are shown in Fig.  5c. The most 
upregulated gene (FC  =  27.30) was cytochrome P450 
family (cyp) 11, subfamily a, member 1 (cyp11a1), 
which is involved in the glucocorticoid and steroid 
pathways catalysing the conversion of cholesterol to 
pregnenolone during gonad formation [48]. We found 
other gene members of the cytochrome P450 super-
family also upregulated: 17β-hydroxysteroid dehydro-
genase 3 (hsd17b3), which is predominantly expressed 
in the testis, catalysing the conversion of androstenedi-
one to testosterone [49] and cytochrome P450 family 
26 subfamily B member 1 (cyp26b1), which degrades 
retinoic acid [50]. In contrast, hsd11b1, which cataly-
ses the conversion of the stress hormone cortisol to the 
inactive metabolite cortisone [51], was downregulated, 
together with other male-related genes such as spermat-
ogenesis-associated (spata) 6 like spata6  l, spata4 and 
azoospermia-associated protein 1 (dazap1). The oes-
trogen receptor (esr) 2a, esr2b and folliculogenesis-spe-
cific BHLH transcription factor (figl) were upregulated, 
whereas zona pellucida glycoprotein 2 (zp2l2) and ovar-
ian tumour suppressor candidate 2 (ovca2) genes were 
downregulated.
We identified three enriched Kegg pathways that were 
upregulated: focal adhesion (dre04510), oxidative phos-
phorylation (dre00190) and regulation of actin cytoskel-
eton (dre04810) as well as ten downregulated Kegg 
pathways (Additional file 6: Table S3). Among them, the 
most enriched was the mTOR signalling pathway. We 
also found one reproduction-related pathway, progester-
one-mediated oocyte maturation (dre04914), which was 
also inhibited. Next, we looked at four pathways typically 
associated with female development in zebrafish [43] (I: 
Fanconi anaemia, II: Wnt signalling, III: oocyte meio-
sis and IV: progesterone-mediated oocyte maturation), 
as well as four pathways typically associated with male 
development (V: PPAR signalling, VI: p53 signalling, VII: 
cytokine–cytokine interaction and VIII: cardiac muscle 
contraction) [43]. The fold change in the expression of 
genes belonging to these eight signalling pathways in the 
ovaries of 5-aza-dC-treated females compared to control 
females ranged approximately from − 2 to + 3 (Fig. 6a, 
b and Additional file 7: Table S4). Thus, in each pathway 
there were upregulated and downregulated genes. How-
ever, in the four pro-female pathways most genes were 
downregulated and these accounted for 78–90% of the 
total number of genes in each pathway (Fig. 6c). In con-
trast, the number of up- and downregulated genes was 
similar in two of the pro-male pathways (PPAR and p53 
PCA1 (64.0%)
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Fig. 5 Transcriptomic effects in ovaries treated with 75 µM of 5-aza-
dC during gonadal development (10–30 dpf ). a Clustering of fish 
based on their ovarian transcriptomic profiles at 90 dpf as assessed by 
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microarray. Full gene names are listed in Additional file 5: Table S2
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signalling), while in the cytokine–cytokine interaction 
pathway the number of upregulated genes clearly pre-
dominated, whereas in the cardiac muscle contraction 
pathway it was the opposite (Fig. 6b, d).
Finally, we investigated genes with a known epigenetic-
related function and we found a total of 40 DEG which 
were classified according to their regulatory mechanisms 
[35, 52] (Fig. 7 and Additional file 8: Table S5): chroma-
tin-related, e.g. chromatin assembly factor 1 subunit A 
(chaf1a); CpG binding domain, e.g. methyl–CpG bind-
ing domain protein 3a (mbd3a); demethylases, e.g. lysine 
(K)-specific demethylase 5Bb (kdm5bb); dicer, e.g. ribo-
nuclease type III (dicer1); histone-related, e.g. histone 
cluster 1 H4c (hist1h4c), methyltransferases, e.g. calmo-
dulin–lysine N–methyltransferase (camkmt), and poly-
comb-associated proteins, e.g. chromobox homologue 
4 (cbx4). Regardless of their mechanism, 35 out of 40 of 
these genes were downregulated in the ovaries of treated 
females (Fig. 7a). These included all but one methyltrans-
ferase and all but three chromatin-related genes (Fig. 7b).
Discussion
Changes in the methylome are part of normal develop-
ment and occur throughout life in all vertebrates [53]. 
These changes can be artificially induced by DNA meth-
ylation inhibitors, the development of which has been 
fuelled for their promise in the treatment of some types 
of cancer. In fish such as medaka, Oryzias latipes [54], 
zebrafish [27] or goldfish, Carasius auratus [55], the 
effects of early treatment with DNA methylation inhibi-
tors have been studied. Here we report the effects of 
5-aza-dC treatment applied during either early devel-
opment or gonadal development in zebrafish. We show 
for the first time that this DNA inhibitor is able to affect 
not only the process of sexual development but also the 
gonadal transcriptome of adults.
Regarding early developmental treatments, these were 
conducted within the first 2 h after fertilization, since a 
previous study in zebrafish already showed that such 
treatments indeed result in a global DNA hypometh-
ylation [27]. In our study, early treatment with 5-aza-dC 
resulted in lower survival, which was evidenced eight 
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days later. In fact, the toxicity of 5-aza-dC, first reported 
in human cells, prompted the development of less toxic 
and more stable agents such as zebularine [19, 56]. Cyto-
toxic effects have also been reported in medaka [28] and 
are thought to be due to induced DNA hypomethylation, 
emphasizing the importance of DNA methylation for 
proper development [57]. When the 5-aza-dC dose was 
75 µM and exposure included most of the gonadal devel-
opment (10–30  dpf) not only survival but also growth 
was reduced. This reduction in growth is in accord-
ance with a previous study in which zebrafish was fed 
with 5-aza-dC at 10 mg/kg for 32 days and where adult 
females had reduced growth [32].
One of the most striking results found in this study is 
that 5-aza-dC treatment consistently resulted in a sex 
ratio bias towards females in all the experiments per-
formed. This is in line with the results obtained with 
an hermaphroditic fish, the ricefield eel, Monopterus 
albus, in which 5-aza-dC treatment drove the natural 
sex reversal towards female development [58]. Our study 
shows that 5-aza-dC at 75  µM applied during 48 hpf 
was capable to feminize zebrafish. When the exposure 
time was longer (6  dpf ) but the drug was administered 
in lower concentrations (15 and 25  µM) similar results 
were obtained. Further, when exposure lasted longer and 
included the gonadal development period (20–30  dpf) 
the number of females was also significantly increased. 
In contrast, in a recent study in which zebrafish was 
treated with 5-aza-dC during 0–6 dpf, no differences in 
sex ratios were found in the F0, but a shift towards males 
was observed in the F1 [33]. However, in that study group 
spawnings were used and it is thus difficult to ascertain 
the genetic contribution of parents, which can heav-
ily influence the results [43, 46]. Our results are unlikely 
due to differential mortality because the early treatment 
experiments ended at 6 dpf at the latest, well before the 
differentiation of the gonads in zebrafish. Adult stickle-
back, Gasterosteus aculeatus, fed with 5-aza-dC (5 µg/g 
feed) had global DNA changes in both testes and ovaries, 
with significant changes in methylation levels particu-
larly in the testes, indicating that 5-aza-dC is also able to 
affect differentiated gonads [31]. Interestingly, treatment 
with 5-aza-dC of children suffering from acute leukae-
mia resulted in hypogonadism, indicating that 5-aza-dC 
can affect the reproductive tissues in humans as well [59]. 
Taken together, our results with zebrafish along with the 
results in the other fish species mentioned above sug-
gested that epigenetic mechanisms involving DNA meth-
ylation—for example, by decreasing methylation of the 
cyp19a1a promoter in ricefield eel [58]—suggest the pos-
sibility of testing DNA methylation inhibitors as a new 
option to control fish sex ratios as done, for example, in 
fish farming or population control. Nevertheless, further 
research should be carried out in additional species.
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Transcriptomic data from the ovaries of treated 
zebrafish with 75 µM of 5-aza-dC during gonadal devel-
opment showed changes in the expression of genes 
related to reproduction and sex differentiation. We 
identified three affected genes of the P450 cytochrome 
family. The cyp11a1, coding for a key enzyme impli-
cated in steroid biosynthesis, was the highest upregu-
lated reproduction-related gene in ovaries of treated 
zebrafish, although normally higher expression levels 
are found in testes [43]. This gene is mostly expressed 
in the brain, head, kidney and testis of adult fish, but it 
has also been involved in ovarian formation [48, 60]. In 
humans, the expression levels of cyp11a1 also increased 
in placental cells treated with 5-aza-dC [61]. The 
cyp261b gene, which was also upregulated, is involved 
in the sexually dimorphic entry into meiosis in mam-
mals (downregulation in ovaries and upregulation in 
testis) [62, 63]. In zebrafish this role seems to be carried 
on by cyp261a [45], although higher levels of cyp261b 
were found in testis of adult heat-treated males when 
compared to control female ovaries [43]. The cyp17a1 
gene was upregulated in 5-aza-dC-treated lymphocytes 
of infertile men [64], but it was downregulated in our 
study. We also identified an upregulation of two oestro-
gen receptors (esr2a and esr2b), similar to was observed 
in breast cancer cultured cells treated with 5-aza-dC 
[65]. In addition, we identified a downregulation of 
ovarian tumour suppressor candidate 2 (ovca2) gene 
similar to that occurred in 5-aza-dC-treated lung cancer 
cell lines [66].
Zebrafish is a gonochoristic species in which all indi-
viduals initially differentiate female-like gonads. Then, 
the gonads of about half of the fish enter apoptosis and 
are transformed into testis [67]. Zebrafish treated with 
5-aza-dC showed an increase of the number of females; 
thus, the transformation into testis might have been 
interrupted due to the treatment. Treatment also resulted 
in an inhibition, persisting in adults, of four signalling 
pathways associated with female development, while one 
out of four pro-male pathways was clearly upregulated.
This is in agreement with the observation that some 
male-related genes and male-related pathways were 
found upregulated in ovaries of exposed fish, indicat-
ing that permanent but hidden effects of the treatment 
during sex differentiation lasted until adulthood. When 
exposing zebrafish to elevated temperature some females 
remain as such and others become masculinized. How-
ever, recently we discovered that some of the heat-resist-
ant zebrafish females have a male transcriptome [43]. 
Thus, regardless of exposure, either to heat or to a dem-
ethylation agent, some zebrafish females exhibit resistant 
ovaries in terms of form, although they present a tran-
scriptome similar to that of male gonads.
Epigenetic regulatory mechanisms are implicated in sex 
determination/differentiation in a wide variety of organ-
isms, including plants and animals (reviewed in [35]). 
Thus, we also examined genes such demethylases, chro-
matin-related and histone-related genes. The expression 
of most of these genes was inhibited long after the end of 
treatment. This resembles the situation after cancer ther-
apy, where demethylation agents are administered during 
3–6  months [68, 69], but side effects such as hemato-
logic and renal toxicities can persist 9–13  months later 
[70]. The effects of 5-aza-dC are thought to be limited to 
euchromatin, suggesting some sort of genome selectiv-
ity [71]. However, how this favours the development and 
maintenance of the female phenotype is not known.
The observed upregulation of some genes related to 
the epigenetic machinery (e.g. dicer1, ehmt2, hdac11, 
mettl22) is consistent with observations in European sea 
bass juveniles after early exposure to heat [52]. We also 
found a repression of 12 out of 13 methyltransferases 
(e.g. mepce, kmt2ab, ehmt1a, prmt1 and dnmt1). These 
enzymes catalyse the transfer of methyl groups on his-
tones [72]. Some methyltransferases have been identi-
fied in the gonads of fish, for example prmt5, which is 
implicated in oogenesis and spermatogenesis [73], and 
ehmt2, the transgenerational regulation of which was 
recently reported in the testis [74, 75]. Due to its impor-
tant role in DNA methylation of the genome, dnmts are 
the most well-studied methyltransferases, not only in 
mammals, but also in fish. 5-Aza-dC treatment results in 
a hypomethylation of the genome because the complex 
DNA-5-aza-dC depletes the activity of the dnmts by the 
proteasome pathway and activates gene expression [18, 
76, 77]. We found inhibition of dnmt3b in adult testes of 
fish treated for 48  h with 75  µM of 5-aza-dC, but gene 
expression of the two major dnmts in ovaries was not 
affected. However, when treatment included the gonadal 
development (10–30 dpf) period, a significant inhibition 
of dnmt1 expression in the ovaries at 90 dpf was observed 
(Additional file  8: Table S5) despite that just at the end 
of the treatment it expression was increased (Fig.  4g). 
These results are in agreement with observations made in 
Japanese ricefield eel embryos, where dnmt1 and dnmt3b 
expression was enhanced after 5-aza-CR treatment dur-
ing 2 dpf [28]. Dnmt3aa and dnmt3bb.1 were also upreg-
ulated in hatched embryos of Solea senegalensis after 
24 h of 5-aza-CR treatment, while dnmt1 was downregu-
lated [78]; in zebrafish larvae treated with 5-aza-dC dur-
ing 0–6 dpf, where dnmt3bb.2 was upregulated, whereas 
dnmt1 was not [33]. Thus, the responsiveness to 5-aza-
dC treatment can be variable as this drug has multiple 
in vivo targets [79].
Dicer1 is a key enzyme required for miRNA formation, 
and so this gene is involved in transcriptional repression 
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functions [80]. Dicer1 is crucial for oocyte maturation 
in invertebrates [81], and its depletion renders sterile 
females in insects [82]. In zebrafish, dicer1 has no role 
in oocyte maturation as primordial germ cells prolifer-
ate and remain pluripotent to form the adult germ line 
in the dicer1 mutant [83]. However, dicer1 is essential for 
zebrafish development [84]. In this study, we found dicer1 
downregulated in the ovaries after 5-aza-dC treatment 
during sex differentiation process together with other 
epigenetic-related genes. We also found downregulation 
of genes of the polycomb group, which are also repres-
sors of the gene transcription machinery, in particular, 
the polycomb homologue 1 (epc1) and two chromobox 
genes (cbx4 and cbx5). In mammals, the role of the cbx2 
in sex determination and differentiation has been shown 
[85, 86], whereas in Nile tilapia it was demonstrated that 
the expression of cbx1b, cbx3a and cbx5 was sexually 
dimorphic in the gonads [87].
Conclusions
We studied the effects of DNA methylation on verte-
brate sexual development in a well-established model, 
the zebrafish. We report that the demethylating agent 
5-aza-dC results in a sex ratio bias towards females in 
this species. The scarce data in other species point also 
to this direction, but whether this is a truly generalized 
effect is at present unknown. Thus, our results show the 
importance of DNA methylation for proper control of 
sexual development and open new avenues for the poten-
tial control of sex ratios in fish (aquaculture, population 
control). We also show that gene expression patterns of 
reproduction and epigenetic-related genes are affected 
by 5-aza-dC treatment in gonads, suggesting underlying 
DNA methylation changes that should be further studied. 
The long-term effects of treatment with 5-aza-dC at the 
time when the gonads are still not differentiated on the 
resulting adult gonadal transcriptome should be consid-
ered and explored in other situations. This could include, 
for example, prepuberal children treated with DNA-dem-
ethylating drugs as part of cancer therapy, given the fact 
that hypogonadism resulting from these treatments has 
already been reported.
Methods
Animal rearing conditions
Domesticated zebrafish (AB strain) were housed in 2.8-l 
plastic tanks (mod. ZT280) placed in a close-circuit sys-
tem (Aquaneering, San Diego, CA, USA) inside a ther-
moregulated walk-in chamber at the aquarium facility 
of our institute. Inside the chamber the conditions were 
as follows: 12-h light/12-h dark constant photoperiod, 
air temperature of 26 ±  1  °C and humidity of 50 ±  3%. 
The water quality parameters were monitored daily 
(temperature: 28  ±  0.2  °C; pH: 7.2  ±  0.5; conductivity: 
750–900 µS; dissolved oxygen: 6.5–7.0  mg  l−1). Ammo-
nium, nitrite, nitrate, silicate and phosphates were 
checked 2–3 times monthly by the water analysis service 
of our institute to ensure they remained in the appropri-
ate ranges [41]. Fish were fed ad  libitum three times a 
day with a commercial food (AquaSchwarz, Göttingen, 
Germany) according to their developmental stages and 
supplemented with live Artemia nauplii (AF48, INVE 
Aquaculture, Dendermonde, Belgium). Fertilization 
always followed natural spawning involving single-pair 
crossings. Batch size and fertilization rates were deter-
mined for each clutch to ensure values within accepted 
range for this species [41]. Likewise, it was ensured 
that post-hatch survival in the untreated groups was in 
accordance with the OECD’s guidelines for the Fish Sex-
ual Development Test [88]. In order to avoid unwanted 
masculinization due to elevated rearing density, the num-
ber of fish per tank was kept in the range 25–35, based on 
our previous study of effects of density on zebrafish sex 
ratios [89].
Ethics statement
Fish were kept in agreement with the European regula-
tions of animal welfare (ETS N8 123, 01/01/91). Our 
fish facilities are approved for animal experimentation 
by the Ministry of Agriculture and Fisheries (certificate 
number 08039–46–A) in accordance with the Spanish 
law (R.D. 223 of March 1988). The experimental pro-
tocol was approved by the Spanish National Research 
Council (CSIC) Ethics Committee within the project 
AGL2013–41047–R.
5‑Aza‑dC treatments
Early development experiments
Fertilized eggs were reared at 26 ±  1  °C in 6-well Petri 
dishes (Thermo Fisher Scientific, Waltham, MA, USA) 
at 30 eggs/well filled with embryo medium (EM, pH 
7.2  ±  0.5) supplemented with 0.1% methylene blue 
(Sigma-Aldrich, Madrid, Spain). Starting within the first 
2  h post-fertilization (hpf), when zebrafish is sensitive 
to 5-aza-dC treatments [27], embryos were treated with 
5-aza-dC (A3656, Sigma-Aldrich, Saint Louis, USA) 
added to the EM at a final concentration of 0 (control), 5, 
15, 25 or 75 µM (Additional file 9: Fig. S4).
For the 5-, 15- and 25-µM concentrations, treatment 
lasted until 6 dpf. At 2 and 4 dpf, 50% of the EM volume 
was replaced with EM containing fresh 5-aza-dC at the 
appropriate concentration. At 6  dpf, fish were counted 
and thoroughly rinsed in EM and then housed in the 2.8-l 
tanks described above. At 30 dpf fish were counted again 
and a random sample (n =  7) of fish were killed and a 
cross section of the body trunk was cut and flash-frozen 
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in liquid nitrogen until analysis. The remaining fish were 
left alive until 90  dpf. The experiment was replicated 
twice using eggs originating from the same breeding pair 
and involved a total of ~ 600 fertilized eggs.
For the 75-µM concentration, treatment lasted only 
from 0 to 2  dpf, since preliminary trials showed that at 
this concentration survival was unacceptably low with 
longer durations. At 1  dpf, 50% of the EM volume was 
replaced with EM containing fresh 5-aza-dC. At 2  dpf 
embryos were thoroughly rinsed in EM and reared in 
untreated EM. At 4 dpf, 5 pools of 20 larvae each from 
two technical replicates were collected from the 0- and 
75-µM group. Larvae were flash-frozen in liquid nitro-
gen and kept at − 80 °C for further analysis. At 6 dpf, the 
remaining larvae were housed in the 2.8-l tanks described 
above. The experiment was repeated seven times using 
seven different breeding pairs, involving a total of ~ 1260 
fertilized eggs.
The effects of all tested concentrations on survival, 
hatching rate and teratology were monitored daily until 
8 dpf. At 90 dpf, fish were euthanized on iced water fol-
lowed by severing the spinal cord. Survival, growth and 
sex ratios were recorded. To assess sex in adults, we used 
visual inspection of the gonad under a dissecting micro-
scope as previously described [53]. Fish sex was deter-
mined individually after dissection, and the sex ratio was 
calculated for each biological replicate. Gonads were 
carefully dissected and flash-frozen in liquid nitrogen 
and stored at −  80  °C until further analysis (Additional 
file 9: Fig. S4).
Gonadal development experiments
This experiment targeted the period of gonadal sexual 
development in zebrafish [38, 40]. The effects of 5-aza-
dC at 25  µM were studied in three different periods: 
10–20, 20–30 and 10–30  dpf. In the latter period, the 
concentration of 75 µM was also tested (Additional file 9: 
Fig. S4). For each period, 2–4 technical replicates were 
used and the whole experiment was repeated twice. For 
these experiments, larvae obtained from pooled eggs of 
five different broodstock pairs were used. To carry out 
this experiment, 10-dpf larvae were randomly assigned 
to 2.8-l tanks. Treatments were carried out with static 
bath at different nominal 5-aza-dC concentrations (0, 
25 or 75 µM). The tanks were placed inside a large ther-
moregulated tub to ensure constant temperature. Three 
times week during the treatment period, 50% of the 
water in each tank was replaced with water containing 
fresh 5-aza-dC at the appropriate concentration. Once 
all treatments with 5-aza-dC were finished at 30  dpf, 
the water of all tanks was replaced and fish were still 
maintained in the tanks inside the tub for an additional 
2 weeks to ensure complete clearance of the drug before 
being returned to the commercial rack.
Survival was recorded periodically every 5–10  days 
during the course of this experiment. At 30 dpf 12 juve-
nile fish (whole body) per group were flash-frozen indi-
vidually and kept at − 80 °C for further gene expression 
analysis. At 90 dpf all remaining fish were killed and sam-
pled as described above.
Gene expression analysis
Tissues were homogenized with 0.5  ml of TRIzol 
(Sigma), and total RNA was extracted with chloroform, 
precipitated with isopropanol and washed with 75% 
ethanol. Pellets were suspended in 25  µl DEPC–water 
and stored at −  80  °C. Total RNA concentration was 
determined by spectrometry (ND-1000 spectrophotom-
eter, NanoDrop Technologies), and quality was checked 
on a 1% agarose/formaldehyde gel. RNA (200  ng) was 
treated with DNAse I, Amplification Grade (Thermo 
Fisher Scientific Inc., Wilmington, DE, USA H) and 
retrotranscribed to cDNA using SuperScript III RNase 
Transcriptase (Invitrogen, Spain) and Random hexamer 
(Invitrogen, Spain) following the manufacturer’s instruc-
tions. Quantitative PCR (qPCR) was carried out with the 
SYBR Green chemistry (Power SYBR Green PCR Master 
Mix; Applied Biosystems). All qPCRs were run in trip-
licate in optically clear 384-well plates. Cycling param-
eters were: 50  °C for 2 min, 95  °C for 10 min, followed 
by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Finally, 
a temperature-determining dissociation step was per-
formed at 95  °C for 15  s, 60  °C for 15  s and 95  °C for 
15  s at the end of the amplification phase. qPCR data 
were collected by SDS 2.3 and RQ Manager 1.2 software, 
and relative quantity (RQ) values were calculated by 
the 2∆∆Ct method [90, 91]. Specificity for each primer 
pair was also confirmed by dissociation step, primers 
efficiency curves and PCR product sequencing. Primer 
sequences used for gene expression study are shown in 
Additional file 10: Table S6.
Microarray hybridization and analysis
For microarray analysis, RNA samples (n =  4 for con-
trol and n  =  4 for 5-aza-dC groups) from ovaries at 
90  dpf of fish subjected to 75  µM of 5-aza-dC during 
10–30  dpf were used. RNA integrity was measured by 
a Bioanalyzer 2100 (RNA 6000 Nano LabChip kit Agi-
lent, Spain). Samples with a RNA integrity number 
(RIN)  >  8.5 were used for microarray hybridizations. 
Briefly, 50 ng of total RNA was labelled using the Low 
Input Quick Amp Labeling Kit, One-Color (Cy3; Agilent 
Technologies). Samples were hybridized individually in 
a 4 × 44 K Agilent platform (G2519F) at the Barcelona 
Biomedical Research Park (PRBB). cRNA was prepared 
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for overnight hybridization with the corresponding 
buffers during 17 h at 65 °C and washed on the follow-
ing day. Hybridized slides were scanned using an Agi-
lent G2565B microarray scanner (Agilent Technologies, 
USA). Agilent software was used to avoid saturation, 
and feature extraction generated the raw data for further 
preprocessing. Statistical analyses were carried out with 
the statistical language R (2.13.1 version). Array nor-
malization was implemented using the Quantile method 
in the Limma package in R (http://www.R-project.org/). 
P value  <  0.01 threshold was applied to identify genes 
that showed statistically significant differences in gene 
expression from comparisons of interest. Microarray 
analysis software Multiple Experiment Viewer (MeV) 
version 4.8.1 was used to analyse microarray data and 
visualized samples by PCA. For the heatmaps statisti-
cal language R (3.3.2 version) was used with the gplot 
package. The log2 transformation of the fluorescence 
values was used for the statistical analysis. DAVID Bio-
informatic Resources 6.8 and REVIGO software [92, 93] 
was used to analyse and study the enriched gene ontol-
ogy (GO) terms in the DEG between groups. For GO 
terms analysis, a Fisher exact test (P < 0.05) false discov-
ery rate (FDR) corrected for multiple testing was per-
formed using all genes in our microarray as background 
and the DEG of each comparison as query. Microarray 
data were submitted to NCBI’s Gene Expression Omni-
bus (GEO) [94] and are accessible through GEO Series 
accession number GSE93367 (https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE93367).
Microarray was validated by quantifying the gene 
expression of 16 genes by qPCR (Additional file  2: 
Fig. S2D). The genes and the primers used are listed in 
Additional file 10: Table S6. The RNAs of the same indi-
viduals used for microarrays were retrotranscribed, and 
qPCR was performed as previously described. Genes 
were selected based on their importance to reproduction 
(Additional file  5: Table S2) and epigenetics (Additional 
file 8: Table S5) in fish sex determination and differentia-
tion [35, 43, 45–47, 52].
Statistical analysis
Data normality and the homoscedasticity of variances 
were checked with the Kolmogorov–Smirnov’s and 
Levene’s tests, respectively. One-way analysis of vari-
ance (ANOVA) was used to detect possible differences 
among groups in survival, BW and SL. Post hoc multi-
ple comparisons were made with the Tukey’s test. The 
Student’s t test was used to detect differences in gene 
expression analysis by using 2∆Ct values [91]. For sex 
ratio analysis, Chi-squared test with Yate’s correc-
tion was used [95]. All data analyses were performed 
with Stat Graphics software (version 17). Data were 
expressed as mean ± s.e.m. In all tests, differences were 
accepted as significant when P < 0.05.
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Additional files
Additional file 1: Fig. S1. Effects of zebrafish treatment with 5-aza-dC 
at 75 µM during the period of gonadal development (10–30 dpf ). (A) 
External differences between control and 5-aza-dC-treated adult zebrafish 
females at 90 dpf. Scale in cm. (B) Body weight and (C) standard length of 
adults at 90 dpf. Data shown as mean ± s.e.m. (n = 8 and 6 males, and 11 
and 4 females in control and 5-aza-dC groups, respectively). Within each 
sex, significant differences (P < 0.05 for males and P < 0.01 for females) 
in growth were determined by the Student’s t test and are indicated by 
different letters.
Additional file 2: Fig. S2. Microarray analysis. (A) qPCR validation of 
microarray results using 16 genes. (Only 15 datapoints can be seen due to 
overlap.) See Additional file 6: Table S3 for further primer information.
Additional file 3: Table S1. List of enriched GO terms (level 3) found in 
the ovaries of fish treated with 75 µM of 5-aza-dC between 10 and 30 dpf.
Additional file 4: Fig. S3. Third level of gene ontology terms of dif-
ferentially expressed genes found by microarray analysis of ovaries of fish 
subjected to 75 µm of 5-aza-dC between 10 and 30 dpf during gonadal 
development. (A, B, C) show the upregulated GO terms, (D, E, F) show the 
downregulated GO terms, (A, D) biological process, (B, E) cellular compo-
nent and (C, F) molecular function.
Additional file 5: Table S2. List of reproduction-related genes differ-
entially expressed (P < 0.01) obtained by microarray analysis in ovaries of 
zebrafish treated with 75 µM of 5-aza-dC between 10 and 30 dpf.
Additional file 6: Table S3. List of enriched Kegg pathways found in the 
ovaries of fish treated with 75 µM of 5-aza-dC between 10 and 30 dpf.
Additional file 7: Table S4. List of genes found differentially expressed 
in eight pathways associated with female or male development, in the 
ovaries of fish treated with 75 µM of 5-aza-dC between 10 and 30 dpf.
Additional file 8: Table S5. List of epigenetic-related genes differentially 
expressed (P < 0.01) obtained by microarray analysis in ovaries of zebrafish 
treated with 75 µM of 5-aza-dC between 10 and 30 dpf.
Additional file 9: Fig. S4. Experimental design to study the effects of 
5-aza-dC treatment on zebrafish development and survival, growth, sex 
ratio and gene expression. (A) Experiments performed during the early 
stages of development, with treatments either from 0 to 2 or 0–6 days 
post-fertilization. (B) Experiments performed during the gonadal develop-
ment period. In the different experiments, 2–7 biological replicates per 
treatment were used, with 2–3 technical replicates each.
Additional file 10: Table S6. Gene symbols, names, Refseq IDs and 
primer sequences for all genes used in qPCR (in alphabetical order) in this 
study.
Page 14 of 16Ribas et al. Epigenetics & Chromatin  (2017) 10:59 
Acknowledgements
We thank Lia Sarrà, Mónica Genestar and Sergi Ruíz for technical assistance.
Competing interests
The authors declare that they have no competing interests.
Availability of supporting data
The data sets generated during and analysed during the current study are 
available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93367.
Consent for publication
All authors have consented to publication.
Ethical Approval and Consent to participate
All experimental procedures and animal care were carried out according to 
the Animal Ethics Committee of the European regulations of animal welfare 
(ETS N8 123, 01/01/91) and approved by the Spanish National Research Coun-
cil (CSIC) Ethics Committee within the project AGL2013–41047–R.
Funding
Work supported by Ministry of Economy and Competitiveness (MEC) grants 
from Spanish government (“EpiFarm”: AGL2013–41047–R) and Aquagenomics 
(CDS2007-0002) to FP LR was supported by an Epifarm contract.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 13 September 2017   Accepted: 30 November 2017
References
 1. Gardiner-Garden M, Frommer M. CpG Islands in vertebrate genomes. J 
Mol Biol. 1987;196:261–82.
 2. Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 
1986;321:209–13.
 3. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, Platzer M, 
Howell GR, Burrows C, Bird CP, et al. The DNA sequence of the human X 
chromosome. Nature. 2005;434:325–37.
 4. Reik W, Walter J. Genomic imprinting: parental influence on the genome. 
Nat Rev Genet. 2001;2:21–32.
 5. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 
1993;362:709–15.
 6. Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyl-
transferases in the regulation of gene expression. Cell Mol Biol Lett. 
2005;10:631–47.
 7. Pradhan S, Bacolla A, Wells RD, Roberts RJ. Recombinant human 
DNA (cytosine-5) methyltransferase I. Expression, purification, and 
comparison of de novo and maintenance methylation. J Biol Chem. 
1999;274:33002–10.
 8. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian develop-
ment. Cell. 1999;99:247–57.
 9. Razin A, Riggs AD. DNA methylation and gene-function. Science. 
1980;210:604–10.
 10. Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R. Reversal of drug 
resistance in human tumor xenografts by 2’-deoxy-5-azacytidine-induced 
demethylation of the hMLH1 gene promoter. Cancer Res. 2000;60:6039–44.
 11. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation 
profile of human cancer. Cancer Res. 2001;61:3225–9.
 12. Yan PS, Chen CM, Shi HD, Rahmatpanah F, Wei SH, Caldwell CW, Huang 
THM. Dissecting complex epigenetic alterations in breast cancer using 
CpG island microarrays. Cancer Res. 2001;61:8375–80.
 13. Egger G, Liang GN, Aparicio A, Jones PA. Epigenetics in human disease 
and prospects for epigenetic therapy. Nature. 2004;429:457–63.
 14. Lyko F, Brown R. DNA methyltransferase inhibitors and the development 
of epigenetic cancer therapies. J Natl Cancer Inst. 2005;97:1498–506.
 15. Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, 
Selker EU. Inhibition of DNA methylation and reactivation of silenced 
genes by zebularine. J Natl Cancer Inst. 2003;95:399–409.
 16. Jones PA, Taylor SM. Cellular-differentiation, cytidine analogs and DNA 
methylation. Cell. 1980;20:85–93.
 17. Juttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2′-deoxycytidine to mam-
malian-cells is mediated primarily by covalent trapping of dna methyl-
transferase rather than DNA demethylation. PNAS. 1994;91:11797–801.
 18. Stresemann C, Lyko F. Modes of action of the DNA methyltransferase 
inhibitors azacytidine and decitabine. Int J Cancer. 2008;123:8–13.
 19. Saleh MH, Wang L, Goldberg MS. Improving cancer immunotherapy 
with DNA methyltransferase inhibitors. Cancer Immunol Immun. 
2016;65:787–96.
 20. White R, Rose K, Zon L. Zebrafish cancer: the state of the art and the path 
forward. Nat Rev Cancer. 2013;13:624–36.
 21. Cavalieri V, Spinelli G. Environmental epigenetics in zebrafish. Epigenetics 
Chromatin. 2017;10:11.
 22. Jiang L, Zhang J, Wang J-J, Wang L, Zhang L, Li G, Yang X, Ma X, Sun X, Cai 
J, et al. Sperm, but not oocyte, dna methylome is inherited by zebrafish 
early embryos. Cell. 2013;153:773–84.
 23. Potok ME, Nix DA, Parnell TJ, Cairns BR. Reprogramming the maternal 
zebrafish genome after fertilization to match the paternal methylation 
pattern. Cell. 2013;153:759–72.
 24. Potok ME, Nix DA, Parnell TJ, Cairns BR. Reprogramming the maternal 
zebrafish genome after fertilization to match the paternal methylation 
pattern. Cell. 2013;153:759–72.
 25. Mhanni AA, McGowan RA. Global changes in genomic methylation levels 
during early development of the zebrafish embryo. Dev Genes Evol. 
2004;214:412–7.
 26. Wu SF, Zhang H, Hammoud SS, Potok M, Nix DA, Jones DA, Cairns 
BR. DNA methylation profiling in zebrafish. Methods Cell Biol. 
2011;104:327–39.
 27. Martin CC, Laforest L, Akimenko MA, Ekker M. A role for DNA methylation 
in gastrulation and somite patterning. Dev Biol. 1999;206:189–205.
 28. Dasmahapatra AK, Khan IA. DNA methyltransferase expressions in Japa-
nese rice fish (Oryzias latipes) embryogenesis is developmentally regu-
lated and modulated by ethanol and 5-azacytidine. Comput Biochem 
Physiol C: Toxicol Pharmacol. 2015;176–177:1–9.
 29. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, Davidson 
NE. Role of estrogen receptor gene demethylation and DNA methyl-
transferase DNA adduct formation in 5-aza-2’-deoxycytidine-induced 
cytotoxicity in human breast cancer cells. J Biol Chem. 1997;272:32260–6.
 30. Bouwmeester MC, Ruiter S, Lommelaars T, Sippel J, Hodemaekers HM, 
van den Brandhof EJ, Pennings JLA, Kamstra JH, Jelinek J, Issa JPJ, et al. 
Zebrafish embryos as a screen for DNA methylation modifications after 
compound exposure. Toxicol Appl Pharmacol. 2016;291:84–96.
 31. Aniagu SO, Williams TD, Allen Y, Katsiadaki I, Chipman JK. Global genomic 
methylation levels in the liver and gonads of the three-spine stickleback 
(Gasterosteus aculeatus) after exposure to hexabromocyclododecane and 
17-beta oestradiol. Environ Int. 2008;34:310–7.
 32. Olsvik PA, Williams TD, Tung HS, Mirbahai L, Sanden M, Skjaerven KH, 
Ellingsen S. Impacts of TCDD and MeHg on DNA methylation in zebrafish 
(Danio rerio) across two generations. Comp Biochem Physiol Toxicol 
Pharmacol: CBP. 2014;165:17–27.
 33. Kamstra JH, Sales LB, Alestrom P, Legler J. Differential DNA methylation at 
conserved non-genic elements and evidence for transgenerational inher-
itance following developmental exposure to mono(2-ethylhexyl) phtha-
late and 5-azacytidine in zebrafish. Epigenetics Chromatin. 2017;10:20.
 34. Labbé C, Robles V, Herraez MP. Epigenetics in fish gametes and early 
embryo. Aquaculture. 2017;472:93–106.
 35. Piferrer F. Epigenetics of sex determination and gonadogenesis. Dev Dyn. 
2013;242:360–70.
 36. Navarro-Martín L, Viñas J, Ribas L, Díaz N, Gutiérrez A, Di Croce L, Piferrer 
F. DNA methylation of the gonadal aromatase (cyp19a) promoter is 
involved in temperature-dependent sex ratio shifts in the European sea 
bass. PLoS Genet. 2011;7:1002447.
 37. Si Y, Ding YX, He F, Wen HS, Li JF, Zhao JL, Huang ZJ. DNA methylation 
level of cyp19a1a and foxl2 gene related to their expression patterns 
and reproduction traits during ovary development stages of Japanese 
flounder (Paralichthys olivaceus). Gene. 2016;575:321–30.
Page 15 of 16Ribas et al. Epigenetics & Chromatin  (2017) 10:59 
 38. Bai J, Gong W, Wang C, Gao Y, Hong W, Chen SX. Dynamic methylation 
pattern of cyp19a1a core promoter during zebrafish ovarian folliculogen-
esis. Fish Physiol Biochem. 2016;42:947–54.
 39. Sun LX, Wang YY, Zhao Y, Wang H, Li N, Ji XS. Global DNA methylation 
changes in Nile tilapia gonads during high temperature-induced mascu-
linization. PLoS One. 2016;11:e0158483.
 40. Shao CW, Li QY, Chen SL, Zhang P, Lian JM, Hu QM, Sun B, Jin LJ, Liu SS, 
Wang ZJ, et al. Epigenetic modification and inheritance in sexual reversal 
of fish. Genome Res. 2014;24:604–15.
 41. Ribas L, Piferrer F. The zebrafish (Danio rerio) as a model organism, with 
emphasis on applications for finfish aquaculture research. Rev Aquac. 
2014;6:209–40.
 42. Liew WC, Bartfai R, Lim Z, Sreenivasan R, Siegfried KR, Orban L. Polygenic 
sex determination system in zebrafish. PLoS One. 2012;7:e34397.
 43. Ribas L, Liew WC, Díaz N, Sreenivasan R, Orbán L, Piferrer F. Heat-induced 
masculinization in domesticated zebrafish is family-specific and yields a 
set of different gonadal transcriptomes. PNAS. 2017;114:E941–50.
 44. Wilson CA, High SK, McCluskey BM, Amores A, Yan YL, Titus TA, Anderson 
JL, Batzel P, Carvan MJ III, Schartl M, Postlethwait JH. Wild sex in zebrafish: 
loss of the natural sex determinant in domesticated strains. Genetics. 
2014;198:1291–308.
 45. Rodriguez-Mari A, Canestro C, BreMiller RA, Catchen JM, Yan YL, 
Postlethwait JH. Retinoic acid metabolic genes, meiosis, and gonadal sex 
differentiation in zebrafish. PLoS One. 2013;8:e73951.
 46. Liew WC, Orban L. Zebrafish sex: a complicated affair. Brief Funct Genom. 
2014;13:172–87.
 47. Ribas L, Robledo D, Gómez-Tato A, Viñas A, Martínez P, Piferrer F. 
Comprehensive transcriptomic analysis of the process of gonadal sex dif-
ferentiation in the turbot (Scophthalmus maximus). Mol Cell Endocrinol. 
2016;422:132–49.
 48. Vizziano D, Randuineau G, Baron D, Cauty C, Guiguen Y. Characterization 
of early molecular sex differentiation in rainbow trout, Oncorhynchus 
mykiss. Dev Dyn. 2007;236:2198–206.
 49. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MJ, 
Schwarz HP, Blethen SL, Mendonca BB, Bloise W, et al. Molecular genetics 
and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 defi-
ciency. J Clin Endocrinol Metab. 1996;81:130–6.
 50. Pennimpede T, Cameron DA, MacLean GA, Li H, Abu-Abed S, Petkovich 
M. The role of cyp26 enzymes in defining appropriate retinoic acid 
exposure during embryogenesis. Birth Defects Res Part a-Clin Mol Teratol. 
2010;88:883–94.
 51. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, 
Hewison M, Stewart PM. 11 beta-hydroxysteroid dehydrogenase type 
1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 
2004;25:831–66.
 52. Diaz N, Piferrer F. Lasting effects of early exposure to temperature on the 
gonadal transcriptome at the time of sex differentiation in the European 
sea bass, a fish with mixed genetic and environmental sex determination. 
BMC Genom. 2015;16:679.
 53. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 
2002;16:6–21.
 54. Iida A, Shimada A, Shima A, Takamatsu N, Hori H, Takeuchi K, Koga A. 
Targeted reduction of the DNA methylation level with 5-azacytidine 
promotes excision of the medaka fish Tol2 transposable element. Genet 
Res. 2006;87:187–93.
 55. Zhang X, Li H, Qiu Q, Qi Y, Huang D, Zhang Y. 2,4-Dichlorophenol induces 
global DNA hypermethylation through the increase of S-adenosylme-
thionine and the upregulation of dnmts mRNA in the liver of gold-
fish Carassius auratus. Comp Biochem Physiol C: Toxicol Pharmacol. 
2014;160:54–9.
 56. Yoo CB, Cheng JC, Jones PA. Zebularine: a new drug for epigenetic 
therapy. Biochem Soc Trans. 2004;32:910–2.
 57. Andersen IS, Lindeman LC, Reiner AH, Ostrup O, Aanes H, Alestrom P, Col-
las P. Epigenetic marking of the zebrafish developmental program. Curr 
Top Dev Biol. 2013;104:85–112.
 58. Zhang Y, Zhang S, Liu Z, Zhang L, Zhang W. Epigenetic modifications dur-
ing sex change repress gonadotropin stimulation of cyp19a1a in a teleost 
ricefield eel (Monopterus albus). Endocrinology. 2013;154:2881–90.
 59. Rivard GE, Momparler RL, Demers J, Benoit P, Raymond R, Lin KT, Mom-
parler LF. Phase-I study on 5-aza-2′-deoxycytidine in children with acute-
leukemia. Leuk Res. 1981;5:453–62.
 60. Blasco M, Fernandino JI, Guilgur LG, Strussmann CA, Somoza GM, Vizzi-
ano-Cantonnet D. Molecular characterization of cyp11a1 and cyp11b1 
and their gene expression profile in pejerrey (Odontesthes bonariensis) 
during early gonadal development. Comp Biochem Physiol A: Mol Integr 
Physiol. 2010;156:110–8.
 61. Hogg K, Robinson WP, Beristain AG. Activation of endocrine-related gene 
expression in placental choriocarcinoma cell lines following DNA meth-
ylation knock-down. Mol Hum Reprod. 2014;20:677–89.
 62. Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, Yashiro 
K, Chawengsaksophak K, Wilson MJ, Rossant J, et al. Retinoid signaling 
determines germ cell fate in mice. Science. 2006;312:596–600.
 63. Koubova J, Menke DB, Zhou Q, Capel B, Griswold MD, Page DC. Retinoic 
acid regulates sex-specific timing of meiotic initiation in mice. PNAS. 
2006;103:2474–9.
 64. Park JH, Lee J, Kim CH, Lee S. The polymorphism (−600 C > A) of CpG 
methylation site at the promoter region of CYP17A1 and its association of 
male infertility and testosterone levels. Gene. 2014;534:107–12.
 65. Bovenzi V, Momparler RL. Antineoplastic action of 5-aza-2 ‘-deoxycytidine 
and histone deacetylase inhibitor and their effect on the expression of 
retinoic acid receptor beta and estrogen receptor alpha genes in breast 
carcinoma cells. Cancer Chemother Pharmacol. 2001;48:71–6.
 66. Prowse AH, Vanderveer L, Milling SWF, Pan ZZ, Dunbrack RL, Xu XX, God-
win AK. OVCA2 is downregulated and degraded during retinoid-induced 
apoptosis. Int J Cancer. 2002;99:185–92.
 67. Orban L, Sreenivasan R, Olsson PE. Long and winding roads: testis dif-
ferentiation in zebrafish. Mol Cell Endocrinol. 2009;312:35–41.
 68. Kantarjian H, Issa JPJ, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, 
Klimek V, Slack J, de Castro C, Ravandi F, et al. Decitabine improves patient 
outcomes in myelodysplastic syndromes—results of a Phase III rand-
omized study. Cancer. 2006;106:1794–803.
 69. Derissen EJB, Beijnen JH, Schellens JHM. Concise drug review: azacitidine 
and decitabine. Oncologist. 2013;18:619–24.
 70. Silverman LR, McKenzie DR, Peterson BL, Holland JF, Backstrom JT, Beach 
CL, Larson RA. Further analysis of trials with azacitidine in patients with 
myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer 
and Leukemia Group B. J Clin Oncol. 2006;24:3895–903.
 71. Ramos MP, Wijetunga NA, McLellan AS, Suzuki M, Greally JM. DNA dem-
ethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchroma-
tin, and has limited transcriptional consequences. Epigenetics Chromatin. 
2015;8:11.
 72. Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, Werner J, Wang YM, 
Chuikov S, Valenzuela P, Tempst P, Steward R, et al. PR-Set7 is a nucleo-
some-specific methyltransferase that modifies lysine 20 of histone H4 
and is associated with silent chromatin. Mol Cell. 2002;9:1201–13.
 73. Chen W, Cao M, Yang Y, Nagahama Y, Zhao H. Expression pattern of 
prmt5 in adult fish and embryos of medaka, Oryzias latipes. Fish Physiol 
Biochem. 2009;35:325–32.
 74. Tse AC-K, Li J-W, Wang SY, Chan T-F, Lai KP, Wu RS-S. Hypoxia alters testicu-
lar functions of marine medaka through microRNAs regulation. Aquat 
Toxicol. 2016;180:266–73.
 75. Wang SY, Lau K, Lai K-P, Zhang J-W, Tse AC-K, Li J-W, Tong Y, Chan T-F, 
Wong CK-C, Chiu JM-Y, et al. Hypoxia causes transgenerational impair-
ments in reproduction of fish. Nature Communications. 2016;7:12114.
 76. Chuang JC, Yoo CB, Kwan JM, Li TW, Liang G, Yang AS, Jones PA. Compari-
son of biological effects of non-nucleoside DNA methylation inhibitors 
versus 5-aza-2′-deoxycytidine. Mol Cancer Ther. 2005;4:1515–20.
 77. Ghoshal K, Datta J, Majumder S, Bai SM, Kutay H, Motiwala T, Jacob ST. 
5-Aza-deoxycytidine induces selective degradation of DNA methyltrans-
ferase 1 by a proteasomal pathway that requires the KEN box, bromo-
adjacent homology domain, and nuclear localization signal. Mol Cell Biol. 
2005;25:4727–41.
 78. Firmino J, Carballo C, Armesto P, Campinho MA, Power DM, Manchado M. 
Phylogeny, expression patterns and regulation of DNA Methyltransferases 
in early development of the flatfish, Solea senegalensis. BMC Dev Biol. 
2017;17:11.
 79. Liu K, Wang YF, Cantemir C, Muller MT. Endogenous assays of dna meth-
yltransferases: evidence for differential activities of dnmt1, dnmt2, and 
dnmt3 in mammalian cells in vivo. Mol Cell Biol. 2003;23:2709–19.
 80. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. 
A cellular function for the RNA-interference enzyme Dicer in the matura-
tion of the let-7 small temporal RNA. Science. 2001;293:834–8.
Page 16 of 16Ribas et al. Epigenetics & Chromatin  (2017) 10:59 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 81. Zhang XY, Lu K, Zhou Q. Dicer1 is crucial for the oocyte maturation of 
telotrophic ovary in Nilaparvata lugens (stal) (Hemiptera: geometroidea). 
Arch Insect Biochem Physiol. 2013;84:194–208.
 82. Tanaka ED, Piulachs MD. Dicer-1 is a key enzyme in the regulation of 
oogenesis in panoistic ovaries. Biol Cell. 2012;104:452–61.
 83. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, 
Hammond SM, Bartel DP, Schier AF. MicroRNAs regulate brain morpho-
genesis in zebrafish. Science. 2005;308:833–8.
 84. Wienholds E, Koudijs MJ, van Eeden FJM, Cuppen E, Plasterk RHA. The 
microRNA-producing enzyme Dicer1 is essential for zebrafish develop-
ment. Nat Genet. 2003;35:217–8.
 85. Katoh-Fukui Y, Tsuchiya R, Shiroishi T, Nakahara Y, Hashimoto N, Noguchi 
K, Higashinakagawa T. Male-to-female sex reversal in M33 mutant mice. 
Nature. 1998;393:688–92.
 86. Katoh-Fukui Y, Miyabayashi K, Komatsu T, Owaki A, Baba T, Shima Y, 
Kidokoro T, Kanai Y, Schedl A, Wilhelm D, et al. Cbx2, a polycomb group 
gene, is required for sry gene expression in mice. Endocrinology. 
2012;153:913–24.
 87. Liu XY, Zhang XB, Li MH, Zheng SQ, Liu ZL, Cheng YY, Wang DS. Genome-
wide identification, evolution of chromobox family genes and their 
expression in Nile tilapia. Comp Biochem Physiol B: Biochem Mol Biol. 
2016;203:25–34.
 88. OECD. Test No. 234: Fish sexual development test OECD Publishing, Paris; 
2011.
 89. Ribas L, Valdivieso A, Diaz N, Piferrer F. Appropriate rearing density in 
domesticated zebrafish to avoid masculinization: links with the stress 
response. J Exp Biol. 2017;220:1056–64.
 90. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 
2001;25:402–8.
 91. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the compara-
tive CT method. Nat Protoc. 2008;3:1101–8.
 92. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis 
of large gene lists using DAVID bioinformatics resources. Nat Protoc. 
2009;4:44–57.
 93. Supek F, Bosnjak M, Skunca N, Smuc T. REVIGO summarizes and visualizes 
long lists of gene ontology terms. PLoS One. 2011;6:e21800.
 94. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene 
expression and hybridization array data repository. Nucl Acids Res. 
2002;30:207–10.
 95. Fowler J, Cohen L, Jarvis P. Practical statistics for field biology. Chichester: 
Wiley; 2008.
